These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12906331)

  • 41. Molecular interactions in celecoxib-PVP-meglumine amorphous system.
    Gupta P; Bansal AK
    J Pharm Pharmacol; 2005 Mar; 57(3):303-10. PubMed ID: 15807985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of thermal stability of indinavir sulphate using diffuse reflectance infrared spectroscopy.
    Singh P; Premkumar L; Mehrotra R; Kandpal HC; Bakhshi AK
    J Pharm Biomed Anal; 2008 Jun; 47(2):248-54. PubMed ID: 18280078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.
    Nijhawan M; Santhosh A; Babu PR; Subrahmanyam CV
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1163-72. PubMed ID: 23829186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling.
    Patterson JE; James MB; Forster AH; Lancaster RW; Butler JM; Rades T
    Int J Pharm; 2007 May; 336(1):22-34. PubMed ID: 17174493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of recrystallization of amorphous trehalose through hot-humidity stage X-ray powder diffraction.
    Jójárt-Laczkovich O; Katona G; Aigner Z; Szabó-Révész P
    Eur J Pharm Sci; 2016 Dec; 95():145-151. PubMed ID: 27496047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine.
    Kasten G; Nouri K; Grohganz H; Rades T; Löbmann K
    Int J Pharm; 2017 Nov; 533(1):138-144. PubMed ID: 28947246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In situ amorphisation of indomethacin with Eudragit® E during dissolution.
    Priemel PA; Laitinen R; Grohganz H; Rades T; Strachan CJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1259-65. PubMed ID: 24056054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Formulation, characterization, and in vivo evaluation of celecoxib-PVP solid dispersion nanoparticles using supercritical antisolvent process.
    Ha ES; Choo GH; Baek IH; Kim MS
    Molecules; 2014 Dec; 19(12):20325-39. PubMed ID: 25486246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation between Molecular Mobility and Physical Stability in Pharmaceutical Glasses.
    Mehta M; Ragoonanan V; McKenna GB; Suryanarayanan R
    Mol Pharm; 2016 Apr; 13(4):1267-77. PubMed ID: 26895136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spectroscopic study on the interaction of celecoxib with human carbonic anhydrase II: thermodynamic characterization of the binding process.
    Mehrabi M; Ghobadi S; Khodarahmi R
    J Photochem Photobiol B; 2009 Dec; 97(3):161-8. PubMed ID: 19879770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility.
    Gupta P; Chawla G; Bansal AK
    Mol Pharm; 2004; 1(6):406-13. PubMed ID: 16028352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modification of the crystal habit of celecoxib for improved processability.
    Banga S; Chawla G; Varandani D; Mehta BR; Bansal AK
    J Pharm Pharmacol; 2007 Jan; 59(1):29-39. PubMed ID: 17227618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simultaneous Differential Scanning Calorimetry-Synchrotron X-ray Powder Diffraction: A Powerful Technique for Physical Form Characterization in Pharmaceutical Materials.
    Clout A; Buanz AB; Prior TJ; Reinhard C; Wu Y; O'Hare D; Williams GR; Gaisford S
    Anal Chem; 2016 Oct; 88(20):10111-10117. PubMed ID: 27642771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.
    Rahman Z; Samy R; Sayeed VA; Khan MA
    Pharm Dev Technol; 2012; 17(4):457-65. PubMed ID: 21265708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glycine phases formed from frozen aqueous solutions: revisited.
    Surovtsev NV; Adichtchev SV; Malinovsky VK; Ogienko AG; Drebushchak VA; Manakov AY; Ancharov AI; Yunoshev AS; Boldyreva EV
    J Chem Phys; 2012 Aug; 137(6):065103. PubMed ID: 22897314
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on the applicability of tamarind kernel powder as a carrier in the dissolution enhancement of poorly water soluble drug, celecoxib.
    Babu GV; Gowrisankar V; Himasankar K; Murthy KV
    Boll Chim Farm; 2003; 142(2):76-82. PubMed ID: 12705095
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of different "states" of sorbed water on amorphous celecoxib.
    Shete G; Kuncham S; Puri V; Gangwal RP; Sangamwar AT; Bansal AK
    J Pharm Sci; 2014 Jul; 103(7):2033-2041. PubMed ID: 24801826
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Celecoxib Crystallized from Hydrophilic Polymeric Solutions Showed Modified Crystalline Behavior with an Improved Dissolution Profile.
    Sahoo RN; Satapathy BS; Ray J; Dash R; Mallick S
    Assay Drug Dev Technol; 2021; 19(4):237-245. PubMed ID: 33970022
    [No Abstract]   [Full Text] [Related]  

  • 59. Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential.
    Remenar JF; Peterson ML; Stephens PW; Zhang Z; Zimenkov Y; Hickey MB
    Mol Pharm; 2007; 4(3):386-400. PubMed ID: 17497886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective.
    Gupta P; Kakumanu VK; Bansal AK
    Pharm Res; 2004 Oct; 21(10):1762-9. PubMed ID: 15553220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.